Treatment Approaches and Biomarkers PRevalence In de Novo MEtastatic Hormone-sensitive Prostate Cancer in Russian Federation

Non-Interventional Study PREVENT

NCT02155998 ·Status: COMPLETED

Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer

NCT00500110 ·Status: COMPLETED ·Phase: PHASE2

CyberKnife® as Monotherapy or Boost SBRT for Intermediate or High Risk Localized Prostate Cancer

NCT01985828 ·Status: COMPLETED ·Phase: NA

Metastasis-directed Therapy for Oligorecurrent Prostate Cancer

NCT05352178 ·Status: RECRUITING ·Phase: PHASE3

Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.

NCT01123434 ·Status: COMPLETED

Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone

NCT00223145 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Exercise for Advanced Prostate Cancer: a Multicomponent Feasibility Trial

NCT03658486 ·Status: COMPLETED ·Phase: NA

To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients

NCT03017313 ·Status: COMPLETED

Chemotherapy, Hormone Therapy, and Surgery to Remove the Prostate Gland in Patients With High Risk Prostate Cancer

NCT00108290 ·Status: COMPLETED ·Phase: PHASE2

Metastatic Prostate Cancer Men's Attitudes Towards Treatment of the Local Tumour and Metastasis Evaluative Research

NCT04590976 ·Status: COMPLETED

A Study to Investigate the Impact of Abiraterone Acetate and Enzalutamide on Health-related Quality of Life, Participant-Reported Outcomes, and Medical Resource Use in Metastatic Castration-resistant Prostate Cancer Participants

NCT02813408 ·Status: COMPLETED

Safety, Tolerability and Pharmacokinetics of ONC1-0013B in Patients With Progressive Metastatic Castration-resistant Prostate Cancer

NCT03074032 ·Status: COMPLETED ·Phase: PHASE1

Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer

NCT01734681 ·Status: WITHDRAWN ·Phase: PHASE2

Gene Expression in Patients With Metastatic Prostate Cancer Receiving CYP-17 Inhibition Therapy

NCT01953640 ·Status: ACTIVE_NOT_RECRUITING

Observational Retrospective Trial on Sequential Hormonal Therapy in Patients With Prostate Cancer

NCT00668083 ·Status: COMPLETED

Fulvestrant in Hormone Refractory Prostate Cancer

NCT00476645 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy Trial of a RNActive®-Derived Prostate Cancer Vaccine in Hormone Refractory Disease

NCT00831467 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Impact of New Generation Hormono-therapy on Cognitive Functions in Elderly Patients Treated for a Metastatic Prostate Cancer

NCT02907372 ·Status: COMPLETED ·Phase: NA

A Study of Single-Agent AT-101 in Men With Hormone Refractory Prostate Cancer

NCT00286806 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

CytoREductive prostAtectomy for Poly-metastatic Hormone sensiTIVE Prostate Cancer

NCT06306612 ·Status: RECRUITING ·Phase: NA

Open Label Prostate Cancer Study

NCT01162395 ·Status: COMPLETED ·Phase: PHASE1

Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate Cancer

NCT00551044 ·Status: COMPLETED ·Phase: NA

PROCARE - PROstate Cancer Real World Evidence Registry

NCT06835218 ·Status: RECRUITING

A Long Term Safety Study With Atrasentan

NCT00127478 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies

NCT03611686 ·Status: ACTIVE_NOT_RECRUITING